← All Neurometrix, INC filings

Neurometrix, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NURO
Neurometrix, INC
10-K/A: NeuroMetrix Files Amended 10-K to Include Key Disclosures
NeuroMetrix, Inc. files an amendment to its annual report on Form 10-K to include required disclosures in Part III, Items 10, 11, 12, 13 and 14, and Item 15 of Part IV.
NURO
Neurometrix, INC
10-K: NeuroMetrix Amends Shareholder Rights Agreement Amidst Merger with electroCore, Sells DPNCheck Assets in Japan
NeuroMetrix amends its Shareholder Rights Agreement and finalizes an asset purchase agreement for its DPNCheck business in Japan, amidst an ongoing merger with electroCore.
NURO
Neurometrix, INC
10-K: NeuroMetrix Reports Full Year 2023 Results, DPNCheck Sales Decline Offset by Quell Growth
NeuroMetrix's 2023 financial results show a significant decrease in DPNCheck revenue due to Medicare Advantage reimbursement changes, partially offset by growth in Quell sales.